Position in AMGN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$2,937,517
-$5,004 QoQ
Shares Held
8,112
-3.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.37%
of 13F equity value
Holder Rank
#1,089
of 3,139 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cypress Capital, LLC holds $13,403,943 across 6 Drug Manufacturers - General names. AMGN ranks #3 (21.9% of the industry book) .
All Filings in AMGN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,937,517 | 8,112 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $2,942,521 | 8,363 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,769,042 | 8,460 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,352,137 | 8,335 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $2,402,602 | 8,605 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,682,133 | 8,609 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $2,199,540 | 8,439 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $2,622,144 | 8,138 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,578,337 | 8,252 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $2,330,286 | 8,196 | Shares | Sole | 2024-10-29 | |
| 2023-12-31 | $2,422,824 | 8,412 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $2,237,427 | 8,325 | Shares | Sole | 2023-11-09 | |
| No filing history on record for this holder in this stock. | ||||||